No abstract available
Keywords:
FGFR; biliary tract cancer; biomarkers; precision medicine; resistance mechanisms; targeted therapy.
MeSH terms
-
Bile Duct Neoplasms* / drug therapy
-
Bile Ducts, Intrahepatic
-
Cholangiocarcinoma* / drug therapy
-
Humans
-
Molecular Targeted Therapy